Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 5
Results: 62
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1088, doi. 10.1111/apt.70025
- By:
- Publication type:
- Article
Letter on 'Head‐To‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study' Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1084, doi. 10.1111/apt.70018
- By:
- Publication type:
- Article
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1086, doi. 10.1111/apt.70011
- By:
- Publication type:
- Article
Letter on 'Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study'.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1082, doi. 10.1111/apt.70008
- By:
- Publication type:
- Article
Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1071, doi. 10.1111/apt.70006
- By:
- Publication type:
- Article
Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1075, doi. 10.1111/apt.70003
- By:
- Publication type:
- Article
Editorial: Examining Perianal Fistulising Crohn's Disease Through the Lens of Wound Repair.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1073, doi. 10.1111/apt.70001
- By:
- Publication type:
- Article
Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1069, doi. 10.1111/apt.18529
- By:
- Publication type:
- Article
Editorial: Alpha<sub>2</sub>‐Delta Ligands in Irritable Bowel Syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1067, doi. 10.1111/apt.18528
- By:
- Publication type:
- Article
Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 950, doi. 10.1111/apt.18527
- By:
- Publication type:
- Article
Editorial: Autoimmune Hepatitis—Could It Be as Easy as Vitamin D?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1065, doi. 10.1111/apt.18524
- By:
- Publication type:
- Article
Letter: Toward Intra‐Class Switching With JAK Inhibitors? Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 921, doi. 10.1111/apt.18521
- By:
- Publication type:
- Article
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021. Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1080, doi. 10.1111/apt.18520
- By:
- Publication type:
- Article
Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1063, doi. 10.1111/apt.18519
- By:
- Publication type:
- Article
Letter: Toward Intra‐Class Switching With JAK Inhibitors?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 919, doi. 10.1111/apt.18518
- By:
- Publication type:
- Article
Letter: The Hidden Truth of IBD Risk—From Antibiotics to Environmental Factors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1090, doi. 10.1111/apt.18517
- By:
- Publication type:
- Article
Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 905, doi. 10.1111/apt.18516
- By:
- Publication type:
- Article
Editorial: Safety and Effects of Direct Oral Anticoagulants for Portal Vein Thrombosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1061, doi. 10.1111/apt.18512
- By:
- Publication type:
- Article
Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States—Author's Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1059, doi. 10.1111/apt.18511
- By:
- Publication type:
- Article
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1077, doi. 10.1111/apt.18510
- By:
- Publication type:
- Article
Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1057, doi. 10.1111/apt.18508
- By:
- Publication type:
- Article
Editorial: PCAB Safety: Balancing Potential Long‐Term Risks With Short‐Term Benefits.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 909, doi. 10.1111/apt.18507
- By:
- Publication type:
- Article
Editorial: Flipping the Script—Higher Risk of Hepatocellular Carcinoma With Tenofovir Compared to Entecavir in a French Population‐Based Cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1055, doi. 10.1111/apt.18499
- By:
- Publication type:
- Article
Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations. Authors' Reply'.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 917, doi. 10.1111/apt.18505
- By:
- Publication type:
- Article
Editorial: HBeAg‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations. Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 901, doi. 10.1111/apt.18504
- By:
- Publication type:
- Article
Current Burden of Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease Among US Adults, 2017–2023.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 891, doi. 10.1111/apt.18501
- By:
- Publication type:
- Article
Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 938, doi. 10.1111/apt.18500
- By:
- Publication type:
- Article
Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1043, doi. 10.1111/apt.18506
- By:
- Publication type:
- Article
Meta‐Analysis of Placebo‐Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 776, doi. 10.1111/apt.18498
- By:
- Publication type:
- Article
Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1032, doi. 10.1111/apt.18497
- By:
- Publication type:
- Article
The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1019, doi. 10.1111/apt.18496
- By:
- Publication type:
- Article
Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 756, doi. 10.1111/apt.18495
- By:
- Publication type:
- Article
Letter: Enhancing HCC Surveillance: GES Score Represents an Innovative Simple Effective Tool for Risk Stratification, Patient Safety and Reduced Anxiety—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 913, doi. 10.1111/apt.18494
- By:
- Publication type:
- Article
Editorial: Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease: Its Potential in Early‐Stage Disease—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 897, doi. 10.1111/apt.18493
- By:
- Publication type:
- Article
A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1011, doi. 10.1111/apt.18492
- By:
- Publication type:
- Article
Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 903, doi. 10.1111/apt.18490
- By:
- Publication type:
- Article
Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 803, doi. 10.1111/apt.18487
- By:
- Publication type:
- Article
Global Burden of Gallbladder Cancer Attributable to Modifiable Risk Factors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 886, doi. 10.1111/apt.18486
- By:
- Publication type:
- Article
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1000, doi. 10.1111/apt.18484
- By:
- Publication type:
- Article
Review Article: Rome Foundation Working Team Report: Consensus Statement on the Design and Conduct of Behavioural Clinical Trials for Disorders of Gut–Brain Interaction.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 787, doi. 10.1111/apt.18482
- By:
- Publication type:
- Article
Letter: Optimising Prevention of Adverse Events and Antiviral Prophylaxis for HBV‐Infected HCC Patients Undergoing Immunotherapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 925, doi. 10.1111/apt.18481
- By:
- Publication type:
- Article
Impact of Nucleos(t)ide Analogs on Major Clinical Outcomes in Patients With Chronic Hepatitis B: A 10‐Year French Nationwide Cohort Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 865, doi. 10.1111/apt.18462
- By:
- Publication type:
- Article
Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 915, doi. 10.1111/apt.18460
- By:
- Publication type:
- Article
Editorial: HBeAg‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 899, doi. 10.1111/apt.18480
- By:
- Publication type:
- Article
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 959, doi. 10.1111/apt.18473
- By:
- Publication type:
- Article
Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 876, doi. 10.1111/apt.18472
- By:
- Publication type:
- Article
Editorial: Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 895, doi. 10.1111/apt.18463
- By:
- Publication type:
- Article
Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 988, doi. 10.1111/apt.18477
- By:
- Publication type:
- Article
Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and Survival.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 971, doi. 10.1111/apt.18474
- By:
- Publication type:
- Article
COLOFIT: Development and Internal‐External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic Patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 852, doi. 10.1111/apt.18459
- By:
- Publication type:
- Article